![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1671919
¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå : Á¦Ç° À¯Çüº°, À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°Leadless Pacemakers Market, By Product Type, By Type, By End User, By Geography |
¼¼°èÀÇ ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀº 2025³â¿¡ 8¾ï 410¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 19¾ï 6,520¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³âÀÇ CAGRÀº 13.6%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
º¸°í¼ ¹üÀ§ | º¸°í¼ »ó¼¼ ³»¿ë | ||
---|---|---|---|
±âÁØ¿¬µµ | 2024³â | 2025³â ½ÃÀå ±Ô¸ð | 8¾ï 410¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2020-2024³â | ¿¹Ãø ±â°£ | 2025-2032³â |
¿¹Ãø ±â°£: 2025-2032³â CAGR: | 13.60% | 2032³â °¡Ä¡ ¿¹Ãø | 19¾ï 6,520¸¸ ´Þ·¯ |
¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿´Â °¡½¿À» Àý°³ÇÏÁö ¾Ê°í ´ëÅð°ñ ¶Ç´Â °æÇÇÀûÀ¸·Î ½ÉÀå¿¡ Á¢±ÙÇÏ¿© ½ÉÀå¿¡ À̽ÄÇϴ ÷´Ü ½ÉÀå ¹Úµ¿±âÀÔ´Ï´Ù. ±âÁ¸ ½É¹ÚÁ¶À²±â°¡ ½É¹ÚÁ¶À²±â¿¡¼ ½ÉÀå±îÁö ¿ÍÀ̾ ´ç°Ü¼ °¡½¿ÀÇ ÇÇÇÏ·Î À̽ÄÇÏ´Â °Í°ú ´Þ¸®, ¹«½É½Ç ½É¹ÚÁ¶À²±â´Â ½ÉÀå¿¡ Á÷Á¢ À̽ĵǸç, ¿ÍÀ̾ ¾ø½À´Ï´Ù. ½É¹ÚÁ¶À²±â ¸®µå¼±°ú °ü·ÃµÈ ÇÕº´Áõ °¨¼Ò, ȯÀÚÀÇ ÀÚ±â°ø¸í¿µ»ó(MRI) °Ë»ç¿¡ ´ëÇÑ ÀûÇÕ¼º Áõ°¡ µîÀÇ ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ÀüÀÚ±â±âÀÇ ¼ÒÇüÈ¿Í ¹èÅ͸® ¼ö¸íÀÌ Çâ»óµÊ¿¡ µû¶ó ½É¹ÚÁ¶À²±â´Â ¼¸Æ Ä¡·á¿¡ Á¡Á¡ ´õ ¸¹Àº Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ÇâÈÄ ¼ö³â°£ ¹«½É½Ç Àΰø½ÉÀå¹Úµ¿±â¿¡ ´ëÇÑ Àü ¼¼°è ¼ö¿ä´Â Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀº ½ÉÇ÷°ü Áúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡, ¹Úµ¿±â ½Ã½ºÅÛÀÇ ¼ÒÇüȸ¦ °¡´ÉÇÏ°Ô ÇÏ´Â ±â¼ú ¹ßÀü, ÇÕº´Áõ °¨¼Ò ¹× ÀÚ±â°ø¸í¿µ»ó(MRI) ȣȯ¼º µî ±âÁ¸ ¹Úµ¿±â ´ëºñ ¹«½ÉÀå ½Ã½ºÅÛÀÌ Á¦°øÇÏ´Â ÀåÁ¡¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÇÏ´Â ÀåÁ¡¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ±×·¯³ª ±âÁ¸ ½É¹ÚÁ¶À²±â¿¡ ºñÇØ ³ôÀº ºñ¿ë°ú ¹èÅ͸® ¼ö¸í¿¡ ´ëÇÑ ¹®Á¦°¡ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹èÅ͸® ¼ö¸íÀÌ °³¼±µÈ ¿ÏÀü ¹«¹Úµ¿ ÆäÀÌ½Ì ½Ã½ºÅÛÀÇ µµÀÔÀº Å« ¼ºÀå ±âȸ·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì¿Í À¯·´ÀÇ ½ÅÈï ±¹°¡ ½ÃÀåÀÌ ÇöÀç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÁö¸¸, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÅÈï ±¹°¡µéÀÌ ÇâÈÄ ¼ö³â°£ ³ôÀº ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ °³¿äÀ» Á¦°øÇÕ´Ï´Ù.
º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷¿¡´Â Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, EBR Systems Inc., MicroPort Scientific Corporation, Biotronik SE &Co.KG, St. Jude Medical(ÇöÀç´Â Abbott »êÇÏ), Osypka AG, Lepu Medical Technology, Cardiac Rhythm Management(CRM), AtriCure Inc., Cook Medical, Sorin Group, Biotronik, Neovasc Inc. µîÀÌ Æ÷ÇԵ˴ϴÙ.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¸®µå¸®½º ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
The Global Leadless Pacemakers Market is estimated to be valued at USD 804.1 Mn in 2025 and is expected to reach USD 1,965.2 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 804.1 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 13.60% | 2032 Value Projection: | USD 1,965.2 Mn |
Leadless pacemakers are advanced cardiac pacemakers that are implanted via femoral or trans-cutaneous access in the heart rather than through incisions in the chest. Unlike traditional pacemakers that are implanted under the skin in the chest with wires running from the pacemaker to the heart, leadless pacemakers are directly implanted in the heart and have no wires. They offer advantages such as reducing complications related to pacemaker leads and enabling more compatibility with magnetic resonance imaging (MRI) scans for patients. With advancements in miniaturization of electronics and improvements in battery life, leadless pacemakers are increasingly gaining popularity for treatment of bradycardia. Their global demand is projected to grow substantially in the coming years.
The global leadless pacemakers market is driven by rising geriatric population worldwide that is susceptible to cardiovascular diseases, technological advancements enabling miniaturization of pacemaker systems, and benefits offered by leadless systems over traditional pacemakers such as reducing complications and enabling Magnetic Resonance Imaging, MRI compatibility. However, high cost of leadless pacemakers compared to traditional ones and issues regarding battery longevity act as restraints for the market. Introduction of completely leadless pacing systems with improved battery life by players presents a major growth opportunity. Regionally, developed markets in North America and Europe currently dominate the market but emerging countries in Asia Pacific are expected to provide high growth opportunities in the coming years.
This report provides in-depth analysis of the global leadless pacemakers market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global leadless pacemakers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, EBR Systems Inc., MicroPort Scientific Corporation, Biotronik SE & Co. KG, St. Jude Medical (now part of Abbott), Osypka AG, Lepu Medical Technology, Cardiac Rhythm Management (CRM), AtriCure Inc., Cook Medical, Sorin Group, Biotronik, and Neovasc Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global leadless pacemakers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leadless pacemakers market